Integrative review and evaluation of quality of life related instruments in pediatric urology.

Outcome measurement Patient reported outcome measures Quality of life Urology

Journal

Journal of pediatric urology
ISSN: 1873-4898
Titre abrégé: J Pediatr Urol
Pays: England
ID NLM: 101233150

Informations de publication

Date de publication:
08 2021
Historique:
received: 28 10 2020
revised: 18 02 2021
accepted: 02 03 2021
pubmed: 10 4 2021
medline: 15 10 2021
entrez: 9 4 2021
Statut: ppublish

Résumé

While most paediatric urologists consider patients' quality of life (QOL) important, few actually measure this outcome. Our goal was to assess instruments used in the pediatric urology QOL literature, specifically looking at whether they captured QOL. We searched MEDLINE and EMBASE for articles with a self-described primary outcome of measuring QOL. All validated QOL instruments in the papers were analyzed by QOL instrument content experts. Instruments were classified as focusing on: Functioning or QOL (Table). The term Functioning focuses on performing activities. QOL captures person's perceptions about their position in life, informed by circumstances, functioning and conditions. QOL instruments were further subdivided into generic QOL, health-related QOL (HRQOL) and disease-specific HRQOL. Only direct patient self-reported QOL instruments were then assessed, since they are the most clinically useful, reliably assessing patients' own perception of their QOL. Forty-three publications met inclusion criteria (published 1999-2019). Most common conditions included urinary incontinence (16, 37.2%) and kidney transplantation (12, 27.9%). Overall, 22 unique instruments purporting to measure QOL were identified. Looking at the concepts measured by each instrument, nine instruments (40.9%) assessed Functioning. Nine instruments (40.9%) measured a combination of Functioning and QOL. Only the remaining 4 instruments (18.2%) assessed strictly QOL. The 13 instruments assessing any QOL focused on generic QOL (n = 4), HRQOL (n = 3) and disease-specific HRQOL (n = 6). Of the subset of four instruments assessing strictly QOL, and not Functioning, all had patient self-reported versions available: two generic QOL instruments (KINDL, KIDSCREEN), one generic HRQOL (DISABKIDS), and one disease-specific HRQOL (QUALAS). Thirteen of 43 studies (30.2%) employed more than one instrument. Thirty-eight studies (88.4%) used an instrument measuring Functioning, with 19 (44.1%) measuring only Functioning, not QOL at all. Twenty-four studies (55.8%) used an instrument measuring actual QOL, although 17 (39.5%) used a combined Functioning/QOL instrument. Only nine (20.9%) used a strictly QOL instrument (strictly HRQOL instruments: 4.7%). We present encouraging evidence of sustained interest in QOL research in pediatric urology and identify areas needing improvement. Selecting appropriate QOL tools requires a working knowledge of their various underlying meanings and purposes. Whether it adequately assess QOL must be considered. We discuss strengths and weaknesses of instruments and a practical approach to QOL instrument selection. Much of pediatric urology is grounded in improving QOL. Unfortunately, most studies published to date focus on Functioning, rather than young people's perception-based QOL. Future QOL studies should ideally employ validated instruments capturing patient-reported QOL.

Identifiants

pubmed: 33832872
pii: S1477-5131(21)00127-3
doi: 10.1016/j.jpurol.2021.03.011
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

443.e1-443.e14

Subventions

Organisme : NCBDD CDC HHS
ID : U01 DD001240
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors have no conflicts of interest relevant to this article to disclose.

Auteurs

Lucshman Raveendran (L)

Division of Urology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Martin Koyle (M)

Division of Urology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Darius Bagli (D)

Division of Urology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Kornelia Twardowski (K)

Division of Urology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Nicolas Cicci (N)

Division of Urology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Gabriel M Ronen (GM)

Division of Pediatric Neurology, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Kathleen J Sawin (KJ)

Department of Nursing Research and Evidence-Based Practice, Children's Hospital of Wisconsin, Milwaukee, WI, College of Nursing, University of Wisconsin-Milwaukee, USA.

Konrad M Szymanski (KM)

Division of Pediatric Urology, Riley Hospital for Children at Indiana University Health, Indianapolis, IN, USA. Electronic address: szymanko@iupui.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH